Trials / Completed
CompletedNCT04866771
Remotely Supervised tDCS for Slowing ALS Disease Progression
Remotely Supervised Transcranial Direct Current Stimulation for Slowing Disease Progression in Amyotrophic Lateral Sclerosis (ALS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Most ALS care is centered on patient support and symptom management, making rehabilitation an integral aspect for slowing disease progression, prolonging life span, and increasing quality of life. Brain stimulation has been increasingly explored as a promising neuromodulatory tool to prime motor function in several neurological disorders. We propose a novel mechanism using remotely supervised brain stimulation to preserve motor function in individuals with ALS. This project will also aim to explore the effectiveness of brain stimulation on upper and lower motor neuron mechanisms in individuals with ALS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Transcranial Direct Current Stimulation (tDCS) | Noninvasive brain stimulation |
| OTHER | Sham tDCS + anodal tDCS | Fake noninvasive brain stimulation or anodal noninvasive brain stimulation |
Timeline
- Start date
- 2021-08-27
- Primary completion
- 2024-07-01
- Completion
- 2025-01-01
- First posted
- 2021-04-30
- Last updated
- 2025-08-07
- Results posted
- 2025-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04866771. Inclusion in this directory is not an endorsement.